Wells Fargo’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Sell
81,795
-108,589
-57% -$1.73M ﹤0.01% 3667
2025
Q4
$3.09M Buy
190,384
+75,599
+66% +$1.23M ﹤0.01% 3088
2025
Q3
$1.72M Buy
114,785
+36,013
+46% +$439K ﹤0.01% 3421
2025
Q2
$918K Buy
78,772
+7,797
+11% +$70.8K ﹤0.01% 3745
2025
Q1
$527K Buy
70,975
+1,689
+2% +$13K ﹤0.01% 4055
2024
Q4
$415K Buy
69,286
+14,807
+27% +$81.6K ﹤0.01% 4318
2024
Q3
$279K Buy
54,479
+667
+1% +$2.91K ﹤0.01% 4362
2024
Q2
$195K Buy
53,812
+15,289
+40% +$48.5K ﹤0.01% 4527
2024
Q1
$124K Buy
38,523
+4,145
+12% +$16K ﹤0.01% 4775
2023
Q4
$168K Buy
34,378
+6,933
+25% +$31.6K ﹤0.01% 4572
2023
Q3
$150K Sell
27,445
-22,372
-45% -$148K ﹤0.01% 4536
2023
Q2
$334K Buy
49,817
+16,547
+50% +$123K ﹤0.01% 4243
2023
Q1
$294K Buy
33,270
+9,214
+38% +$81.2K ﹤0.01% 4197
2022
Q4
$184K Sell
24,056
-816
-3% -$6.35K ﹤0.01% 4218
2022
Q3
$178K Sell
24,872
-10,052
-29% -$94.7K ﹤0.01% 4309
2022
Q2
$283K Sell
34,924
-679
-2% -$5.97K ﹤0.01% 4099
2022
Q1
$493K Buy
35,603
+12,088
+51% +$190K ﹤0.01% 4412
2021
Q4
$660K Sell
23,515
-3,376
-13% -$103K ﹤0.01% 4448
2021
Q3
$915K Sell
26,891
-8,450
-24% -$306K ﹤0.01% 4302
2021
Q2
$1.44M Sell
35,341
-781,117
-96% -$30.4M ﹤0.01% 3964
2021
Q1
$32.9M Sell
816,458
-521,369
-39% -$28.2M 0.01% 1297
2020
Q4
$79.1M Buy
1,337,827
+234,854
+21% +$12.1M 0.02% 745
2020
Q3
$53.6M Buy
1,102,973
+191,746
+21% +$8.06M 0.01% 831
2020
Q2
$44.1M Buy
911,227
+26,293
+3% +$959K 0.01% 910
2020
Q1
$24.6M Buy
884,934
+666,308
+305% +$18.6M 0.01% 1133
2019
Q4
$6.54M Buy
218,626
+3,858
+2% +$111K ﹤0.01% 2328
2019
Q3
$6.64M Buy
214,768
+109,969
+105% +$4.49M ﹤0.01% 2295
2019
Q2
$5.06M Buy
+104,799
New +$4.64M ﹤0.01% 2564

Other funds holding ADPT